Adverum Biotechnologies, Inc.
Developing single-injection gene therapies for prevalent ocular diseases like wet AMD.
ADVM | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00773U2078
- LEI:
- Country:
- United States of America
- Address:
- 100 CARDINAL WAY, 94063 REDWOOD CITY
- Website:
- https://adverum.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Adverum Biotechnologies, Inc. is a clinical-stage company aiming to establish gene therapy as a new standard of care for highly prevalent ocular diseases. The company develops potential functional cures to restore vision and prevent blindness. Its proprietary technology is a next-generation adeno-associated virus (AAV) vector platform for intravitreal (IVT) administration. Adverum's lead program, Ixo-vec (ixoberogene soroparvovec), is an investigational treatment for wet age-related macular degeneration (wet AMD). It is designed as a single, in-office injection that transforms retinal cells into 'biofactories' to continuously produce a therapeutic protein (aflibercept), thereby aiming to eliminate the need for frequent injections and offer a durable, long-term treatment benefit.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Adverum Biotechnologies, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Adverum Biotechnologies, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Adverum Biotechnologies, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
